Software Platform Designed for Managing, Using, and Sharing Image Data in the Treatment of Cancer
By MedImaging International staff writers Posted on 20 May 2014 |
A new update of an oncology software platform provides clinicians with a range of new tools that simplifies the use of diverse types of images and automates time-consuming image-processing tasks that are essential to treating cancer with image-guided radiotherapy or radiosurgery.
Velocity software is designed to access and aggregate unstructured treatment and imaging data from diverse systems to show a wide-ranging view of a patient’s diagnostic imaging and treatment history, irrespective of where they were treated or what technology was implemented. The software enables healthcare professionals to use oncology patient images and data to plan and evaluate treatments, collaborate with colleagues, and share clinical knowledge. By organizing patient data and making it available in one place, the Velocity software can help clinicians make more knowledgeable treatment decisions.
This latest Velocity software release adds a range of new applications that make it easier to combine images, calculate the likely impact of different doses of radiation on tumors, and normal tissues, automate several complex image handling processes, and use the program to communicate and collaborate with colleagues.
Varian Medical Systems (Palo Alto, CA, USA) acquired the Velocity software platform from a privately-held Atlanta, GA, USA, firm in April 2014. “We’re very pleased with how the integration process is going, and looking forward to sharing this latest Velocity release with Varian customers and others interested in our growing collection of tools for data-driven clinical decision making,” said Tim Fox, associate vice president, imaging informatics at Varian. “The Velocity software product will be among the products highlighted within the Varian booth at the upcoming annual meetings of the American Association of Medical Dosimetrists [AAMD] and the American Association of Physicists in Medicine [AAPM] later this year.”
Related Links:
Varian Medical Systems
Velocity software is designed to access and aggregate unstructured treatment and imaging data from diverse systems to show a wide-ranging view of a patient’s diagnostic imaging and treatment history, irrespective of where they were treated or what technology was implemented. The software enables healthcare professionals to use oncology patient images and data to plan and evaluate treatments, collaborate with colleagues, and share clinical knowledge. By organizing patient data and making it available in one place, the Velocity software can help clinicians make more knowledgeable treatment decisions.
This latest Velocity software release adds a range of new applications that make it easier to combine images, calculate the likely impact of different doses of radiation on tumors, and normal tissues, automate several complex image handling processes, and use the program to communicate and collaborate with colleagues.
Varian Medical Systems (Palo Alto, CA, USA) acquired the Velocity software platform from a privately-held Atlanta, GA, USA, firm in April 2014. “We’re very pleased with how the integration process is going, and looking forward to sharing this latest Velocity release with Varian customers and others interested in our growing collection of tools for data-driven clinical decision making,” said Tim Fox, associate vice president, imaging informatics at Varian. “The Velocity software product will be among the products highlighted within the Varian booth at the upcoming annual meetings of the American Association of Medical Dosimetrists [AAMD] and the American Association of Physicists in Medicine [AAPM] later this year.”
Related Links:
Varian Medical Systems
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow